Solid Biosciences Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $80.0M | $76.0M |
| FY2020 | — | $132.1M | $154.7M |
| FY2021 | — | $208.2M | $119.1M |
| FY2022 | — | $211.7M | $155.4M |
| FY2023 | — | $126.5M | $74.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $80.0M | $76.0M |
| FY2020 | — | $132.1M | $154.7M |
| FY2021 | — | $208.2M | $119.1M |
| FY2022 | — | $211.7M | $155.4M |
| FY2023 | — | $126.5M | $74.0M |